1. Introduction {#sec1}
===============

Accidents with *Crotalus durissus terrificus* (*C.d. terrificus*) are an important public health issue in South America ([@bib13]). In Argentina, envenomation caused by this species is of medical importance due to the lethality of their venom ([@bib24]). Such cases are often fatal, when treatment with specific antivenom is not quickly administered ([@bib1], [@bib5], [@bib15]).

Neurotoxic paralysis is the major clinical effect in envenomation by *C.d.terrificus,* whereas local effects are small or even absent ([@bib42]). The envenomation causes neurotoxic, myotoxic, and coagulopathic effects ([@bib1]). Regarding systemic myotoxicity, it could lead to acute renal failure, also with tubular necrosis ([@bib3], [@bib4]).

In general terms, the venomic of *C.d.terrificus* comprises toxins from different protein families: phospholipases A~2~, serine proteinases, 5′nucleotidases, metalloproteinases, nerve growth factors, phosphodiesterases, glutaminylcyclase, C-type lectin, crotamine, L-amino acid oxidase and disintegrins ([@bib6], [@bib25], [@bib27], [@bib50]). Additionally, using different bottom-up approaches, [@bib33] provided more information about the proteomic characterization of this venom. They also describe the presence of CRISP, phospholipase-B, snake venom vascular endothelial growth factor (svVEGF) and other proteins involved in the regulation of toxin synthesis and processing ([@bib33]).

Venomic analysis is a tool to evaluate new sources of biologically compounds of therapeutic value ([@bib37]). It is also important for better understanding the ecological and evolutionary relationships among snake species, and for the preparation of more effective toxin-specific antivenoms. Regarding evolution, some authors show the distributional history of the neotropical rattlesnake in South America and the Amazon. The phylogeographic pattern of *C.durissus sp.* is best explained by a Pleistocene trans-Amazonian corridor of continuous distribution: past savanna or dry forest vegetation [@bib2]). *C. d .terrificus* is a subspecies that it is found only in South America and its geographical distribution is shown in [Fig. 1](#fig1){ref-type="fig"} (<http://www.reptile-database.org/>).Fig. 1C.d*. terrificus* distribution in South America (green area), reptile area follows the electronic database accessible at <http://www.reptile-database.org> accessed on 14 May 2020. Symbols indicate the approximate regions of origin of the snakes sampled in previous and present work: ■;-[@bib50],•- [@bib33], ▲- [@bib6], O -- [@bib25], Ф Present work.Fig. 1

*C.d. terrificus whole* venom as well as some isolated toxins (PLA~2~, SVSP) from specimens that inhabit in Argentina, were further studied with respect to the toxicological properties ([@bib1], [@bib22], [@bib23], [@bib32], [@bib40], [@bib41], [@bib39], [@bib43]), but no previous proteomic reports have been found. Knowledge about the toxins from venoms is the basis for the treatment of victims, and the selection of specimens for the preparation of venom pools for antivenom production ([@bib27]). Here we used a fast and direct venomics approach ([@bib11], [@bib12], [@bib27]) to identify the toxin families in the *C.d. terrificus* rattlesnake.

2. Material and methods {#sec2}
=======================

2.1. Venom {#sec2.1}
----------

*Crotalus d. terrificus* venom was pooled from 25 specimens of adult snakes held in the serpentarium of the local Zoo (CEPSAN), Corrientes, Argentina. The venom was lyophilized and kept frozen at −20 °C.

2.2. Reverse phase (RP) HPLC {#sec2.2}
----------------------------

Five mg of *C.d. terrificus* venom were dissolved in 200 mL of solvent A (0.1% (v/v) trifluoroacetic acid; TFA). The resulting solution was clarified by centrifugation at 5000×*g* for 5 min and the supernatant was applied to a Discovery C18 column (4.6 mm × 25 cm; Akta Purifier system). Proteins were eluted with a gradient (0--20%, 20--60%, 60--100%) of 66% (v/v) acetonitrile in solvent B, at a flow rate of 1 mL/min. The elution profile was monitored at 215 nm and the fractions were collected, dried in speed vac and stored at −20 °C. Values of area under the curve were used to estimate the relative abundance of each protein family (%).

### 2.2.1. Protein mass determination by mass spectrometry {#sec2.2.1}

The dried samples from RP-HPLC fractions were re-dissolved (in 0.1% acetic acid) and analyzed using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer (Axima Performance, Shimadzu). One microliter of each sample was co-crystallized with 1 μL of sinapic acid matrix (saturated solution prepared in 50% ACN/0.1% acetic acid) in the plate and dried at room temperature. The mass spectrum was obtained in the 50--50,000 mass/charge (m/z) range, in linear positive mode.

### 2.2.2. Protein identification by proteomic analysis {#sec2.2.2}

The samples from RP-HPLC fractions were buffered in ammonium bicarbonate 50 mM, pH7), and then dithiothreitol (10 mM final concentration) was added and left for 1 h at 60 °C; after that, iodoacetamide(IAA) (10 mM final concentration) was added and incubated for 1 h, at room temperature and protected from light. Next, 10 μL of trypsin (40 ng μL^−1^ in 100 mMTris-HCl, pH 8.5) was added. The incubation was performed overnight, at room temperature. The reaction was stopped by adding 50% ACN/5% TFA.

The samples were then analyzed by liquid chromatography-mass spectrometry using an ESI-IT-TOF (LCMS-IT-TOF/Shimadzu Co., Kyoto, Japan) system coupled to a binary ultra-fast liquid chromatography system (UFLC) (20A Prominence, Shimadzu). Each sample was loaded in a C18 column (Discovery C18, 5 μm; 50 × 2.1 mm) in a binary solvent system: (A) water: acetic acid (999:1, v:v) and (B) ACN: water: acetic acid (900:99:1, v:v:v). The column was eluted at a constant flow rate of 0.2 mL min^−1^ with a 0--40% gradient of Solvent B over 35 min. The eluates were monitored by a Shimadzu SPD-M20A PDA detector before checking on the mass spectrometer. The interface voltage was 4.5 kV; the capillary voltage was 1.85 kV, at 200 °C; and the fragmentation was induced by argon collision, at 55% 'energy'. MS spectra were acquired under positive mode and collected in the 350--1400 mass/charge (m/z) range. MS/MS spectra were collected in the 50--1950 m/z range.

LCD Shimadzu raw data were converted (LCMS Protein Postrun, Shimadzu) to Mascot Generic Format (MGF) files prior to analyses. Peaks Studio V7.0 (BSI, Toronto, ON, Canada) was used for data processing (de novo peptide sequencing and proteomic identification) ([@bib30]). Peaks Studio V7.0 (BSI, Toronto, ON, Canada) was used for data processing ([@bib30]). Proteomic identification was performed according to the following parameters: error mass (MS and MS/MS) set to 0.2 Da; methionine oxidation and carbamidomethylation as variable and fixed modification, respectively; trypsin method; maximum missed cleavages (3), maximum variable Post-Translational Modifications (PTMs) per peptide (3) and non-specific cleavage (one). The samples were analyzed against a provide specific information on UniProt database ([@bib47]- Total entries 562,253).

2.3. Proteolytic activity {#sec2.3}
-------------------------

Caseinolytic activity was measured colorimetrically by a modified procedure described ([@bib28]) with slight modifications. The reaction mixture, consisting of 142 μL azocasein (5 mg/mL) in PBS (phosphate-buffered saline, pH 7.2), 25 μL venom dilution (5, 2.5, 1.25, 0.6 mg/mL) in PBS buffer, was incubated for 90 min at 37 °C. The reaction was quenched by the addition of 334 μl of 5% trichloroacetic acid and rest for 30 min at room temperature. After centrifugation at 13000×*g* for 5 min, 100 μL of the supernatant was mixed with the equal volume of 0.5 M NaOH and absorbance was measured at 450 nm and the percentage of activity was calculated. *B. alternatus* venom was used as positive control (100% of caseinolytic activity). Assays were run in triplicate including appropriate blanks.

3. Results and discussion {#sec3}
=========================

The combination of RP-HPLC and mass spectrometric analyses was used to identify the major protein components from the crude venom that comes from specimens that inhabit the Northeast region of Argentina. The RP-HPLC separation profile of pooled venom from adult specimens ([Fig. 2](#fig2){ref-type="fig"}), followed by mass spectrometry analysis ([Supplementary Table 1](#appsec1){ref-type="sec"} and [Fig. 1](#appsec1){ref-type="sec"}), revealed that *C.d. terrificus* venom proteome is made up of 12 protein families, which are unevenly distributed in the venom, e.g., there are few major proteins in the venom composition ([Table 1](#tbl1){ref-type="table"}).Fig. 2Characterization of the venom proteome of *C.d. terrificus* from Argentina. Reverse-phase HPLC separations of the proteins from venom of specimens of Crotalus (lower in the panel). Protein Mass Determination by mass spectrometry (upper in the panel).Fig. 2Table 1Assignment of the proteins isolated by reversed-phase HPLC of the *Crotalus durissus terrificus* venom to protein Families by ESI-IT-TOF and proteomic analysis.Table 1HPLC PeakProtein Family%13,15-19Crotoxin basic chain30.7CTX B-chain7--12Crotoxin acid chain30.0CTX A-chain14,19-23Serine Proteinase18.3SVSP2--3Crotamine7.7CTM24--26L-amino-acid oxidase\~ 3.0LAAO26Phosphodiesterase\~ 2.6PDE18Vascular endothelial growth factor\<1.5svVEGF4,5,6,25Zinc metalloproteinase-disintegrin\<1.4SVMP1Bradykinin potentiating and C-type natriuretic peptides\<1.2BBP/C-NP27C-type lectin convulxin\<1CTL28Snake venom 5′-nucleotidase\<0.25′NT28Phospholipase B\<0.2PLB28Venom nerve growth factor\<0.2VNGFUnidentified2.2NI

Our protocol, however, differs from others previously described ([@bib9], [@bib11], [@bib12], [@bib27]). The first step was the separation of one (or several) protein components from the whole venom by reversed-phase chromatography. This was carried out to increase the detection sensitivity for minor components of the protein mixture in the subsequent identification steps. In sequence the mass and complexity of the protein samples were analyzed by MALDI-TOF, and the proteins were identified by ESI-IT-TOF and proteomic analysis.

The venom of *C.d.terrificus* from Brazil has been extensively studied by proteomic methods. In this sense, at least five proteomic studies were found ([@bib6], [@bib13], [@bib25], [@bib33], [@bib50]) four of them as listed in [Table 2](#tbl2){ref-type="table"}. The first proteomic *C.d. terrificus* study was performed by [@bib12], but the geographical origin of the venom is unknown because the venom was purchased from Latoxan (Valence, France). Later, other studies ([Table 2](#tbl2){ref-type="table"}) were performed, and increased information on the composition of venom components, and their relations with geographic and ontogenetic changes of specimens belonging to this subspecies ([Fig. 1](#fig1){ref-type="fig"}). In this sense, variations in the relative quantity of CTX were determined in venoms from different geographic regions and, in general, exceeded 50% of the total venom protein composition. Serine (SVSP) and metaloprotease (SVMP) families were present in all venoms analyzed. Other components were also present in small percentages (≤3%).Table 2Overview of the relative occurrence and comparison with previously studies of protein families identified of *Crotalus durissus terrificus* venom.Table 2Protein FamilyPresent Work1234CTX A/B-chain60.759.548.569.389.4SVSP18.38.225.313.41.43CTM7.719.0ND1NDLAAO\~ 3.04.5ND3NDPDE\~ 2.6ND1.91.20.39svVEGF\<1.5NDNDND2.2SVMP\<1.44.83.92.96BBP/C-NP\<1.22.8ND0.20.04CTL\<11.7ND2.70.025′-NT\<0.2ND7.80.40.39PLB\<0.2NDND0.20.04VNGF\<0.2ND1.90.40.15Non identify2.2ND9.7NDNDGlutaminyl cyclaseNDND1NNDCRISPNDNDND0.2NDHyaluronidaseNDNDND0.80.45[^1][^2][^3][^4]

In this work, the *C.d. terrificus* from Argentina venom proteins were analyzed, and our results showed similar composition to other rattlesnake venoms from Brazilian snakes. However, as discussed below, some differences were detected.

Crotoxin is abundant in the venom of *C.d. terrificus* (60.7%)*,* and this figure is close to information from [@bib33]. As we have previously reported ([@bib22], [@bib23]), PLA~2~ from crotoxin complex (crotoxin basic chain, CTX B-chain) is present in different molecular forms in the venom. This enzyme could be detected in fractions 13 and 15 to 21 in the RP-HPLC separation ([Fig. 2](#fig2){ref-type="fig"}) and accounted for 30.7% of total venom proteins ([Table 1](#tbl1){ref-type="table"}). The molecular masses vary between 13.551,1 and 14.259,7 Da. With a similar abundance (30.0%), crotoxin acid chain (CTX A-chain) was detected in fractions 7 to 12 and their molecular masses were around 10 kDa. Hence, we were able to detect eight molecular forms of CTX B-chain and six of CTX A-chain. This is in agreement to previous studies reported by other authors, who informed that crotoxin is a mixture of variant forms of each component ([@bib19], [@bib18]).

Serine proteinases constitute another large protein family of the *C. d. terrificus* venom. They were present in about 1--25% in all *C.d. terrificus* venom studied ([Table 2](#tbl2){ref-type="table"}). The quantity observed was intermediate (18.3%) in the venom here studied. In RP-HPLC profile the SVSP was detected in a fraction 14 closed to CTX B-chain fractions and in a non-resolved fraction (19--23). This proteinases group featured a molecular mass around 29 kDa, similar to what was reported by [@bib12]. Some SVMPs detected by MS/MS analysis belonging to the fibrinogenases subgroup (peak 21, [Supplementary Data Table 1](#appsec1){ref-type="sec"}). All this evidence agrees with Maruñak and collaborators works, who isolated a 33 kDa (by SDS-PAGE) SVMP from *C.d. terrificus* venom of Argentina. The isolated enzyme exhibited a thrombin-like activity and strong hydrolyzing activity on fibrinogen and fibrin ([@bib32]). These venom serine proteinases may be part of a family with multiple molecular forms ([@bib51]).

Regarding the metalloproteinases, rattlesnake venom from Brazilian specimens present SVMPs in low relative quantities ([@bib13]). The mass spectrometry analysis of RP-HPLC fractions of pooled venom from adult *C.d. terrificus* specimens from Argentina ([Fig. 2](#fig2){ref-type="fig"}), revealed the presence of one peptide belonging to the catalytic domain of SVMP ([Supplementary Data, Table 1](#appsec1){ref-type="sec"}). This evidence was found in fraction 25, a pool of several proteins (LAOO, SVSP, 5′ND, PLB) all in very low quantity. The 25 peak area from RP-HPLC profile represents minor of 2% of total chromatogram area. In agreement with this observation, *C.d.terrificus* venom exhibited a low proteolytic activity. Only the highest concentrations tested (2.5--5 mg venom/mL) were capable of hydrolyze casein, and the activity was 5% of that for *B. alternatus* venom (a well-known venom by its high proteolytic activity) under similar conditions. The activity was not detected at lower venom concentrations assayed. In light of these results, it can be inferred that *C.d. terrificus* venom has SVMP only as traces. This confirms observations that have been reported in previous works. At the same time, the very low level of SVMP detected may explain the lack of hemorrhagic activity, as it was described for this venom. ([@bib1], [@bib24]).

Disintegrins are a family of polypeptides present in the venoms of Viperidae and Crotalidae snakes (vipers and rattlesnakes) ([@bib10]). In the present work, zinc metalloproteinase/disintegrins were detected at the beginning of the chromatogram in fraction 5 ([Fig. 2](#fig2){ref-type="fig"}). Our results are agreement to Wiezel and collaborators who detected two disintegrins isoforms in *C.d. terrificus* venom from Brazilian specimens ([Table 2](#tbl2){ref-type="table"}), while [@bib13], [@bib25] and [@bib33], did not find these proteins in the venoms analyzed. Disintegrins detected in this work showed molecular masses around 7.4 kDa and this value similar to disintegrins isolated from venoms of *Crotalus durissus* subspecies as *C.d.collilineatus* and *C.d.cascavella* ([@bib6]), as well as other Crotalus species and subspecies, such as those studied by [@bib52], *C. atrox* and *C.d. durissus*. Additionally, [@bib44] also reported the characterization of mojastin 1 (7.436 kDa) and 2 (7.636 kDa) with masses around 7.5 kDa present in the venom of *C.s. scutulatus* ([@bib44]). These reports of the presence of disintegrins are from venoms containing SVMPs. The presence of disintegrins could be due to the direct synthesis from short-coding mRNAs ([@bib8]).

On the other hand, a peptide belonging to the prodomain of SVMP was identified by MS/MS analysis of fraction 3 ([Supplementary Data Table 1](#appsec1){ref-type="sec"}). Simultaneously the MALDI-TOF analyses of this fraction showed the presence of proteins with molecular mass around 5 kDa. Although SVMP prodomain peptides are very rare in vipers venome, they have been described in some venoms ([@bib34]).

Taken together, these results could be indicating that the SVMP molecule "pool" in the *C.d. terificus* venom is a mixture of fully- and partially processed (active) metalloproteinases, as well as well as unprocessed zymogens, as described Nicolau and cowokers in *Bothrops jararaca* venom proteopeptidomic analysis ([@bib36]). In [Table 2](#tbl2){ref-type="table"} the percentual content of this proteins family is shown. This value (\<1.4%) is lesser between the obtained values for all *C.d. terrificus* venom studied.

Crotamine represents approximately 8% of the protein composition of the total venom. Here, it was detected in fractions 2 and 3, i.e., variants forms showing molecular masses close to 5 kDa. It is well known that Crotamine is a small basic myotoxin ([@bib17], [@bib38]). Johara [@bib6] reported the increased frequency of crotamine-positive populations from Southeast to Southern Brazil for *C.d. terrificus*. In this sense, some authors describe crotalid venoms as crotamine-positive or --negative specimens and correlating with different toxicological properties ([@bib14], [@bib46]). The *C.d. terrificus* venom from Argentina is crotamine positive as was demonstrated not only in the identification proteomic analysis, but was also previously reported by [@bib16].

Studies from other South American rattlesnakes have pointed increased neurotoxicity southwards along the North-South axis of the species dispersal into South America ([@bib6], [@bib13]). Our results indicate that *C.d.terrificus* venom has a high content of neurotoxins (crotoxin and crotamin). This finding are in concordance with those reported by [@bib13] who showed the gain of neurotoxicity and lethal venom activities to mammals venom toxicity has evolved during *Crotalus durissus* invasion of South America. This analysis was supported by mapping a "lethal neurotoxicity coefficient" (LNC), which these authors define as the ratio between the average LD50 (μg/kg) of the venom and the crotoxin + crotamine concentration ([Supplementary Table 2](#appsec1){ref-type="sec"}).The overall analysis of venom composition, LD50 and LNC of *C. d. cascavella, collilineatus and terrificus* subspecies venoms closely resemble that of *C. d. terrificus* venom from Argentina, supporting the hypothesis that these taxa can be considered geographical variations of the same species ([@bib6]).

L-amino acid oxidase and PDE are usually minor components in the mixture of protein and represent between 1.2 and 3% ([Table 2](#tbl2){ref-type="table"}) of the venom composition.

LAAO was detected at the beginning of RP-chromatography (fraction1), as well as at the end (fractions 24--26) co-eluting with minor protein components, as CTL (\<1%), 5′NT (\<0.2%), PLB (\<0.2%) or VNGF (\<0.2%). In comparison with studies from other authors, this protein was not always detected. In this present work, LAAO represents around three percent of the whole venom. Since it is a large protein, this atypical chromatographic behavior could be due to isoforms or to protein cleavage (either artifactual or already present in the venom). Bordonein-L, the L-amino acid oxidase from *C.d. terrificus*, has been previously studied and characterized ([@bib7], [@bib49]).

Phosphodiesterases (PDE) are one of the lesser abundant enzymes in snake venoms, they hydrolyze phosphodiester bonds from the 3' terminus of polynucleotides producing 5-mononucleotides ([@bib20]). Although PDEs account for only around 2 percent of total venom proteins, it was postulated that this enzyme would induce important clinical disorders during the intoxication process ([@bib31]). In this work, PDE was detected in fraction 26 and represents circa 2.6 percent of the venom proteins. In a previous study, we have identified two PDEs from *C.d. terrificus* from Argentina, with molecular mass of \~ 100 kDa ([@bib21]). Our findings are in accordance with Georgieva and collaborators which identified 2 phosphodiesterase spots thorough proteomic research of the 2D-separated venom ([@bib25]).

The proteome analysis revealed a small set of proteins with a low quantity (less than 1.5%), both enzymes (PLB, 5′NT) and proteins (BBPs, CTL and svVEGF). Their presence in this venom is discussed below.

The first RP-HPLC fraction contained bradykinin potentiating peptides (BBPs). BBPs are prolinerich peptides which structural determinants were recently reviewed by [@bib45]. BBPs have already been isolated from *Crotalus* genera ([@bib26], [@bib29]). From *C.d. terrificus* two homologous cDNAs encoding the BPPs precursor protein were cloned ([@bib26]). These peptides, together with crotamine, represent the two families of *C.d. terrificus* venom small molecules ([@bib48]).

The glycosylated C-type lectin from venom of *C.d. terrificus* (CVX) ([@bib35]) could be identified by reverse-phase separation as the C-type lectinconvulxin, and it was one of the most hydrophobic proteins fractionated. Similar observations were made by other authors when studying the venom of Brazilian snakes ([@bib6], [@bib13], [@bib33], [@bib50]).

In the present work 5′ nucleotidase, phospholipase B and venom nerve growth factor were detected as the most hydrophobic proteins from the *C.d. terrificus* venom (fraction 28) and co-eluted together at the end of RP-HPLC profile. These proteins represent less than 0.2 percent of the proteome.

As it was mentioned, toxicological properties of *C.d. terrificus* venom from Argentina as well as of isolated toxins were further studied. The venomic results here obtained are largely agreeing with previous biochemical venom characterization, and they provide novel information about the presence of proteins (e.g. desintegrins) that, even in low levels, are interesting to isolate and study them.

In conclusion, this proteomic analysis allowed us to identify proteins from *C.d. terrificus* venom from adult snakes that inhabit the north region of Argentina, as well as the comparison to the previously data obtained by authors who studied crotalic venom from Brazil. The results reveal that, despite the geographical proximity, the venom from *C.d. terrificus* presents many similarities and some differences to the Brazilian snake venom. The proteome here described shows, in general, the typical and expected protein composition for *C.d. terrificus* venom. Nevertheless, this crotamine positive venom has a lower metalloprotease content than *C.d. terrificus* venoms from other regions. This information is relevant for the design of pan-south American *C.d.terrificus* antivenom.
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